ABIVAX SA 00370M103 05/11/2026 Approval of the compensation items paid during, or allocated for, the financial year 2025 to Ms. Sylvie Gregoire as Chair of the Board of Directors SECTION 14A SAY-ON-PAY VOTES 0 0 ABIVAX SA 00370M103 05/11/2026 Approval of the compensation items paid during, or allocated for, the financial year 2025 to Mr. Marc de Garidel as Chief Executive Officer SECTION 14A SAY-ON-PAY VOTES 0 0 ASSEMBLY BIOSCIENCES, INC. 045396207 06/04/2026 Approval, on a non-binding advisory basis, of our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 CHENIERE ENERGY, INC. 16411R208 05/14/2026 Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES 0 0 CLEARWATER ANALYTICS HOLDINGS, INC. 185123106 05/06/2026 To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. SECTION 14A SAY-ON-PAY VOTES 0 0 CRESCENT BIOPHARMA, INC. G2545C104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 CRESCENT BIOPHARMA, INC. G2545C104 06/02/2026 To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve compensation for Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 CROSS COUNTRY HEALTHCARE, INC. 227483104 12/09/2025 Proposal to approve, on an advisory basis, compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 GFL ENVIRONMENTAL INC. 36168Q104 05/13/2026 Approval of advisory non-binding resolution on the Company's approach to executive compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 GOLDEN ENTERTAINMENT, INC. 381013101 03/31/2026 To consider and vote on the proposal to approve, on a non binding, advisory basis, the compensation that may be paid or become payable by Golden to its named executive officers in connection with the transactions contemplated by the Master Transaction Agreement (the "Advisory Compensation Proposal") SECTION 14A SAY-ON-PAY VOTES 0 0 JFROG LTD. M6191J100 05/20/2026 To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES 0 0 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES 0 0 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 Approval, on an advisory basis, of thefrequency (every one, two or three years) ofadvisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 0 0 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 MARVELL TECHNOLOGY, INC. 573874104 06/25/2026 An advisory (non-binding) vote to approve compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 NEKTAR THERAPEUTICS 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES 0 0 OCUGEN, INC. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 OCUGEN, INC. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the preferred frequency with which future advisory votes on the compensation of Ocugen's named executive officers should be held. SECTION 14A SAY-ON-PAY VOTES 0 0 POPULAR, INC. 733174700 05/08/2026 Approve, on an advisory basis, the Corporation's executive compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 REPUBLIC AIRWAYS HOLDINGS INC. 590479408 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES 0 0 SUN COMMUNITIES, INC. 866674104 05/12/2026 To approve, by a non-binding advisory vote, executive compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 TRUECAR, INC. 89785L107 12/22/2025 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger (the ''Advisory Compensation Proposal''). SECTION 14A SAY-ON-PAY VOTES 0 0 UL SOLUTIONS INC. 903731107 05/20/2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 0 0 VSE CORPORATION 918284100 05/07/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 ZOOM COMMUNICATIONS, INC. 98980L101 06/11/2026 Approve, on an advisory non-binding basis, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES 0 0